Records containing: Tuberculosis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-10-31
  A Single Arm, 3 Phase Study to Determine the Effect of Intermittent Dosing of Rifampicin on the Pharmacokinetics of Raltegravir in Healthy Volunteers
• CLINICAL_TRIALS study record update · 2013-10-29
  Phase 2 Study of Orally Formulated Heat-killed Mycobacterium Vaccae Study in TB Patients
• CLINICAL_TRIALS study record update · 2013-10-29
  Phase II Open Label, Randomized, Controlled Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-unexposed, BCG Naive Newborn Infants in South Africa
• CLINICAL_TRIALS study record update · 2013-10-01
  A Registry of Tuberculosis Cases in the CPCRA
• CLINICAL_TRIALS study record update · 2013-10-01
  Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2013-09-09
  Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania.
• CLINICAL_TRIALS study record update · 2013-08-30
  ClinicalTrials.gov study NCT01932268
• CLINICAL_TRIALS study record update · 2013-08-29
  The Impact of Deworming on Host Immunity and Clinical Outcome in Patients With Pulmonary Tuberculosis
• CLINICAL_TRIALS study record update · 2013-08-28
  A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PNU-100480 (PF-02341272) After Administration Of Multiple Escalating Oral Doses To Healthy Adult Subjects
• CLINICAL_TRIALS study record update · 2013-08-27
  A Phase 1 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PNU-100480 (PF-02341272) After First Time Administration Of Ascending Oral Doses To Healthy Adult Subjects Under Fed And Fasted Conditions
• CLINICAL_TRIALS study record update · 2013-08-19
  A Phase Ia, Randomized, Placebo-Controlled, Single-Dose, Double-Blind, Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of SQ109 in Normal, Healthy Male and Female Volunteers
• CLINICAL_TRIALS study record update · 2013-07-18
  A Prospective Observational Study of Usefulness of a T Cell-based Assay for Latent Tuberculosis Infection in Hematopoietic Stem Cell Transplant Recipients
• CLINICAL_TRIALS study record update · 2013-07-17
  Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in the Treatment of Tuberculosis Patient With HIV Infection in Vietnam : A Phase II Trial
• CLINICAL_TRIALS study record update · 2013-07-17
  Phase II Open-label Randomized Multicenter Trial to Compare the Efficacy and Safety of Two Different Doses of Raltegravir and Efavirenz, All in Combination With Tenofovir and Lamivudine, in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
• CLINICAL_TRIALS study record update · 2013-07-12
  Evaluation of Efficacy of Thrice Weekly DOTS Regimen in Tubercular Pleural Effusion at 6 Months
• CLINICAL_TRIALS study record update · 2013-07-10
  A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Metronidazole Combined With Antituberculous Chemotherapy vs. Antituberculous Chemotherapy With Placebo in Subjects With Multi-Drug Resistant Pulmonary Tuberculosis
• CLINICAL_TRIALS study record update · 2013-07-02
  A Phase I Trial to Compare the Safety and Immunogenicity of Candidate TB Vaccine MVA85A Administered by the Aerosol Inhaled Route and the Intradermal Route in Healthy BCG-vaccinated Adult Subjects
• CLINICAL_TRIALS study record update · 2013-06-25
  A Phase II, Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Subjects With Newly Diagnosed Sputum Smear-positive Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
• CLINICAL_TRIALS study record update · 2013-06-06
  Multicentre Randomised Control Trial of Point-of-treatment (Clinic-based) Xpert MTB/RIF Assay
• CLINICAL_TRIALS study record update · 2013-05-22
  Phase 2 Randomized Trial of a Moxifloxacin-Containing Regimen For Treatment of Smear-Positive Pulmonary Tuberculosis in Adults With and Without HIV Infection
• CLINICAL_TRIALS study record update · 2013-05-20
  Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya
• CLINICAL_TRIALS study record update · 2013-05-16
  A Phase II, Open-label Trial With TMC207 as Part of a Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Subjects With Sputum Smear-positive Pulmonary Infection With MDR-TB.
• CLINICAL_TRIALS study record update · 2013-05-15
  Rifampicin and Isoniazid Along With Prednisolone Compared to Prednisolone Alone in Treatment of Sarcoidosis: a Pilot Randomized Controlled Trial
• CLINICAL_TRIALS study record update · 2013-05-14
  A Phase 1C, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate the Safety, Tolerability and Pharmacokinetics of 300 mg of SQ109 Given Once Daily for 14 Days in Normal, Healthy Male and Female Volunteers
• CLINICAL_TRIALS study record update · 2013-05-03
  Mentor Mothers: A Sustainable Family Intervention in South African Townships